Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MYO15A |
| Upstream (Parents) |
|---|
| (<<) CLN8 → MYO15A |
| (<<) NMT2 → MYO15A |
| (<<) ALOX12 → MYO15A |
| (<<) C5orf42 → MYO15A |
| (<<) PYHIN1 → MYO15A |
| (<<) ART1 → MYO15A |
| Downstream (Children) |
|---|
| MYO15A → NEUROD4 (>>) |
| MYO15A → GFRA3 (>>) |
| MYO15A → KERA (>>) |
| MYO15A → ZBBX (>>) |
| MYO15A → AK5 (>>) |
| MYO15A → NEUROD2 (>>) |
| MYO15A → DKFZP564C196 (>>) |
| MYO15A → MTAP (>>) |
| MYO15A → ALOX12 (>>) |
| MYO15A → CLEC4E (>>) |
| MYO15A → C5orf42 (>>) |
| MYO15A → HUNK (>>) |
| MYO15A → PHLPP2 (>>) |
| MYO15A → MPP2 (>>) |
| MYO15A → SLC12A3 (>>) |
| MYO15A → MAGOH2 (>>) |
| MYO15A → RAB33A (>>) |
